Disease Management Conferences: Overview

Overview

The disease management enterprise is emerging as one of the major initiatives to make America's healthcare system more efficient and cost effective and to enhance healthcare quality and reduce medical errors. Disease management is proliferating in both the private and public sectors. With new authority from recent legislation, Medicare has become an important new player in actively supporting pilot and demonstration projects dealing with the management of chronic diseases.

Disease management efforts are nested throughout the health system at the employer and plan level, within healthcare providers and in freestanding disease management enterprises. The Disease Management Colloquium presents case studies of disease management efforts in a variety of settings. The Colloquium explores the role of disease management as it affects Medicare, Medicaid, the commercially insured, and the under-and uninsured; the role of evidence-based medicine; the use of incentives for physician and consumers; new tools and techniques; innovations by health plans and disease management companies; and key legislative and policy issues affecting the future of disease management.

The Colloquium seeks to better educate government agencies, the health care industry (including health plans and providers), employers, and the general public about the important role disease management programs play in improving health care quality and outcomes for persons subject to chronic conditions.

We are very pleased to be able to welcome everyone to Philadelphia. We believe this is an outstanding conference and we know you will all enjoy it immensely. We have assembled a top notch faculty and the interaction will be first rate. Disease Management is a dynamic field and in order to stay on top of the details it takes hard work and attention to what the experts have to say.

David B. Nash, MD, MBA, FACP
The Dr. Raymond C. and Doris N. Grandon Professor of Health Policy and Chair of the Department
Jefferson Medical College, Thomas Jefferson University
Philadelphia, PA

Who Should Attend:

Presidents/CEOs/CFOs/COOs

Medical Directors

Medicare Directors

Medicaid Directors

Pharmaceutical, Biotechnology and Medical Device Manufacturers

Managed Care Pharmacy Directors, Pharmacy Managers and Retail Pharmacists

Chain Pharmacists, Community and Independent Pharmacists

Directors and Deputy Directors, State Departments of Public Health

CIOs, CTOs, Vice Presidents and Directors of Information Systems

Directors of Programs in Asthma, Cardiovascular, Oncology, Pain, Behavioral Health, Women's Health, and Alternative Medicine

Vice Presidents, Quality

Vice Presidents, Managed Care

Directors, Disease Management

Physicians

Psychologists

Social Workers

Alternative Medicine Providers

Pharmacy Managers

Retail Pharmacists

Chain Pharmacists

Community/Independent Pharmacists

Course Learning Objectives

To Provide an Overview of the Disease Management Enterprise in the United States and Internationally
To Set Forth Disease Management Initiatives Being Implemented in the Medicare and Medicaid Programs
To Assess How to Achieve and Measure Return on Investment (ROI) from Disease Management Initiatives
To Describe the Implications of Pay for Performance and Other Financial Incentives in Disease Management Programs
To Articulate the Role of Disease Management in Responding to the Institute of Medicine's Challenge to Enhance Healthcare Quality
To Analyze the Role of Health Information Technology in Implementing Disease Management Programs
To Share Best Practices Case Studies Presented by Leading Disease Management Organizations
To Create a Vision for the Role of Employers, Health Plans, Providers, Disease Management Enterprises and Patients in Implementing Successful Disease Management Programs